Canada· CA-DIN-00674354
COLLYRE BLEU LAITER
A naphazoline product containing methylene blue + naphazoline nitrate, registered in Canada by FRILAB SA. The same ATC class is registered in 8 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Naphazoline is registered in 8 of 19 countries.
Countries holding a registration under ATC S01GA01 (naphazoline), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 4 of them publish a price we can compare per daily dose
Naphazoline · ATC S01GA01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- United Kingdom
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- METHYLENE BLUE + NAPHAZOLINE NITRATE
- Manufacturer
- FRILAB SA
- Country
- Canada (CA)
- ATC code
- S01GA01
- ATC class
- Naphazoline
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
53 interactions on record for naphazoline.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naphazoline · interactions on record
53 records
- 7 severe
- 46 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01GA01
Naphazoline, as other registers publish it.
- CanadaALBALONABBVIE CORPORATION
- CanadaCLEAR EYESPRESTIGE BRANDS INC
- DenmarkCleareyesElara Pharmaservices Europe Ltd.
- FinlandCleariElara Pharmaservices Europe Limited
- IcelandCleyeElara Pharmaservices Europe Limited
- NorwayCleyeElara Pharmaservices Europe Ltd
- United KingdomMurine irritation & redness relief 0.012% eye dropsPrestige Brands (UK) Ltd
- IrelandMurine irritation & redness relief, 0.012% w/v, eye drops solutionElara Pharmaservices Europe Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ae0cb3e8-44ef-4a64-aeb1-48813ad2de7a GET /v1/drugs/ae0cb3e8-44ef-4a64-aeb1-48813ad2de7a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "00674354",
"form": "DROPS",
"class": "Human",
"routes": [
"OPHTHALMIC"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "S01GA01",
"schedule": [
"OTC"
],
"drug_code": "7203",
"strengths": [
"0.2 MG",
"0.5 MG"
],
"ahfs_class": null,
"substances": [
"METHYLENE BLUE",
"NAPHAZOLINE NITRATE"
],
"product_categorization": null
}See everything about naphazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.